Major trial tests new Long-Term arthritis treatment
NCT ID NCT07286058
Summary
This study aims to check the long-term safety and effectiveness of the daily pill zasocitinib for adults with active psoriatic arthritis. It is a 2-year follow-up study for about 1,200 people who completed a previous 1-year trial. The main goal is to monitor side effects and see if the drug continues to help control joint pain, swelling, and skin symptoms over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.